Most PD-1+TCF1+ OT1 TILs during the tumor control phase after PD1d/IL-2v/IL-33 ACT expressed higher Gzmc and lower TOX protein relative to canonical TCF1+PD-1+ PEX-like cells from baseline tumors (Fig. 7h). The gene discussed is PDCD1; the disease is neoplasm.